US Medically Prescribed Apps Market Research Report By Type (wellness management app, treatment management app, disease management app, women health pregnancy app, disease-specific app, others), By Device (personal digital assistant, tablet, computer, smartphone, others), By Operating System (android, windows, ios system, others) and By Application (diabetic management, multi-parameter tracker, cardiac monitoring, others) - Forecast to 2035

US Medically Prescribed Apps Market Overview

As per MRFR analysis, the US Medically Prescribed Apps Market Size was estimated at 3.64 (USD Billion) in 2023. The US Medically Prescribed Apps Market Industry is expected to grow from 4.5(USD Billion) in 2024 to 25.2 (USD Billion) by 2035. The US Medically Prescribed Apps Market CAGR (growth rate) is expected to be around 16.955% during the forecast period (2025 - 2035).

Key US Medically Prescribed Apps Market Trends Highlighted

The US Medically Prescribed Apps Market is witnessing significant growth driven by several key market drivers. One primary driver is the increasing adoption of mobile health technologies among healthcare providers and patients, fostering better access to medical care. The rise of chronic diseases has led to the demand for effective monitoring and management tools, which is further supported by advancements in smartphone technology that allow users to track their health metrics easily.

Moreover, regulatory support from government agencies like the FDA, which has established clear guidelines for mobile health applications, encourages the development of new apps, ensuring patient safety and efficacy. There are ample opportunities to be explored in this market, particularly as healthcare providers seek innovative solutions to enhance patient engagement and compliance with treatment plans. Collaborations between tech companies, healthcare professionals, and academic institutions can yield groundbreaking apps that cater to niche medical needs, providing tailored experiences for users.

Additionally, as telehealth continues to evolve in the US, integrating medically prescribed apps with telemedicine services can maximize patient outcomes and streamline healthcare processes. Recent trends indicate a move towards personalization in the development of medically prescribed apps, where algorithms can adapt based on individual patient data, thus improving treatment adherence. Furthermore, there is a growing emphasis on mental health, with a variety of apps emerging to support psychological well-being, reflecting a broader recognition of mental health's importance within the healthcare system.

The US healthcare landscape is progressively shifting to integrate these technologies as standard practice, with a growing body of research and data supporting their efficacy in clinical outcomes.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

US Medically Prescribed Apps Market Drivers

Increase in Chronic Disease Prevalence

The US has seen a significant increase in the prevalence of chronic diseases, a major driver for the US Medically Prescribed Apps Market Industry. According to the Centers for Disease Control and Prevention (CDC), approximately 6 in 10 adults in the US have a chronic disease, and 4 in 10 have two or more. The rise in diseases such as diabetes and hypertension is driving healthcare providers to adopt tailored digital solutions, including medically prescribed applications, to enhance management and patient compliance.

This trend is compounded by the fact that the US healthcare system is focusing on reducing hospital readmissions, with the American Heart Association highlighting that mobile health technologies can help manage these chronic conditions effectively, leading to better patient outcomes. This propels growth in the US Medically Prescribed Apps Market as healthcare providers partner with technology firms to develop innovative solutions.

Technological Advancements in Mobile Health

Rapid advancements in technology significantly influence the US Medically Prescribed Apps Market Industry. Innovations in mobile technology, such as the integration of Artificial Intelligence (AI) and machine learning capabilities into healthcare applications, have been transformative. For instance, the Food and Drug Administration (FDA) has been actively approving more mobile health applications, with a reported increase of 58% in approved software from 2016 to 2020.

These advancements allow for real-time patient monitoring and more personalized treatment plans, enhancing patient engagement and adherence to treatment. Major organizations such as Apple and Google have begun investing heavily in health technologies, creating ecosystems that encourage the development and integration of prescribed apps, thus propelling market growth.

Growing Acceptance of Telemedicine

The acceptance of telemedicine has surged dramatically in the US, particularly following the COVID-19 pandemic. As per the American Medical Association, telehealth visits increased by 50% in 2020 compared to previous years, demonstrating a marked shift in consumer attitudes towards remote healthcare services. This growing acceptance facilitates a conducive environment for the US Medically Prescribed Apps Market Industry, as patients become more comfortable using technology for healthcare.

The Centers for Medicare & Medicaid Services (CMS) have expanded reimbursements for telehealth services, which suggests a sustainable future for remote health solutions. This expansion leads to increased utilization of prescribed apps, as they can effectively complement telemedicine, further driving their adoption.

US Medically Prescribed Apps Market Segment Insights

Medically Prescribed Apps Market Type Insights

The US Medically Prescribed Apps Market is experiencing substantial growth across various types, reflecting the shift towards digital health solutions. As healthcare continues to evolve, the emphasis on effective wellness management apps signifies a growing priority for preventive care, aiming to enhance individual health and lifestyle choices. Treatment management apps are also gaining traction, as they are designed to assist patients in adhering to prescribed treatments and medications, thus improving overall health outcomes.

The importance of disease management apps cannot be overstated, as they empower patients with chronic conditions to take control of their health through real-time data tracking and personalized care plans, facilitating better communication with healthcare providers. Women health pregnancy apps highlight the crucial role of empowering expectant mothers with information and resources tailored to their unique needs, aiding in prenatal care and wellness. Meanwhile, disease-specific apps cater to niche health issues, providing users with specialized information and management tools that address their specific medical conditions. The "others" category captures the diverse range of innovative applications emerging in the market, showcasing the versatility and adaptability of digital health solutions.

The increasing adoption of smartphones and wearable technology in the US is a driving force behind this market segment's growth, with consumers seeking convenient ways to manage their health. Furthermore, the integration of artificial intelligence and machine learning into these apps is creating advanced functionalities, which enhance user experience and promote engagement. The promise of improved health outcomes and reduced healthcare costs positions the US Medically Prescribed Apps Market as a significant player in the broader healthcare landscape, highlighting the increasing reliance on technology to support medical care through various types of applications.

The rising awareness and acceptance of telehealth are also boosting the adoption of medically prescribed apps, reflecting an ongoing trend where patients are more willing to engage with technology to manage their health effectively. As the demand for personalized healthcare options intensifies, the growth and diversification of the US Medically Prescribed Apps Market will likely continue, driven by the continuous development of innovative solutions tailored to meet the unique health needs of American consumers. Overall, the advancement of this market segment illustrates both the opportunities and challenges ahead in the landscape of digital health, underscoring the commitment to improving healthcare access and efficacy throughout the United States.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Medically Prescribed Apps Market Device Insights

The Device segment of the US Medically Prescribed Apps Market is integral to delivering healthcare solutions efficiently. This segment encompasses various devices including personal digital assistants, tablets, computers, smartphones, and others, each playing a distinct role in the healthcare landscape. Among these, smartphones hold a prominent position due to their widespread use and accessibility, offering patients easy access to prescribed medical applications. Tablets also contribute significantly, particularly in clinical settings where larger screens enhance usability for healthcare professionals.

Personal digital assistants and computers remain vital as they provide specialized applications for data management and patient monitoring. The proliferation of these devices is driven by increasing smartphone penetration in the US and the rising adoption of telehealth services, which facilitate remote patient management and engagement. However, challenges such as data security, regulatory compliance, and integrating with existing healthcare systems need to be addressed. The growth in digital health solutions presents opportunities for innovation in device usability and interoperability, underscoring the importance of this segment in enhancing patient outcomes and streamlining healthcare delivery.

As demand for medically prescribed applications rises, the Device segment is expected to play a crucial role in shaping the future of the US Medically Prescribed Apps Market.

Medically Prescribed Apps Market Operating System Insights

The Operating System segment in the US Medically Prescribed Apps Market plays a crucial role in determining the accessibility and functionality of health applications. Various operating systems, including Android, iOS, Windows, and others, provide specific advantages and feature sets that cater to diverse user needs. Android dominates the market owing to its extensive user base and flexibility, allowing healthcare providers to deploy applications tailored to individual patient needs. iOS, on the other hand, is widely recognized for its strong security features and seamless integration with Apple devices, making it a popular choice among healthcare professionals focused on data privacy.

Windows offers robust computing power and is often preferred in clinical settings where larger screens enhance user experience. Additionally, other operating systems also hold a significant niche by catering to specialized applications, particularly in telehealth and remote patient monitoring. As the landscape evolves with more digital health initiatives, understanding the US Medically Prescribed Apps Market segmentation across these operating systems is vital to harnessing opportunities for innovation and growth in the healthcare technology sector.

Medically Prescribed Apps Market Application Insights

The US Medically Prescribed Apps Market focuses significantly on applications that support various health conditions. The diabetic management segment plays a crucial role in helping patients monitor and manage their blood glucose levels, diet, and medication, addressing the increasing prevalence of diabetes in the US. Meanwhile, multi-parameter trackers are gaining traction due to their ability to consolidate numerous health metrics into one app, promoting preventive healthcare and improving patient engagement. Cardiac monitoring applications are vital for individuals with heart conditions, offering real-time data and facilitating timely interventions, which directly contributes to better health outcomes.

Each of these applications highlights the importance of technology in managing chronic diseases, emphasizing trends like remote patient monitoring and personalized health insights. The growing integration of artificial intelligence within these applications is anticipated to enhance user experience and healthcare delivery significantly. Opportunities also lie in expanding functionalities to further align with regulatory requirements and patient needs, making the US Medically Prescribed Apps Market an evolving landscape with vast potential for growth and improvement in healthcare delivery.

US Medically Prescribed Apps Market Key Players and Competitive Insights

The US Medically Prescribed Apps Market is characterized by rapid growth and innovation, driven by advancements in technology and an increasing focus on patient-centered healthcare solutions. Companies operating in this market are navigating a landscape that is not only competitive but also continuously evolving. With the integration of artificial intelligence, data analytics, and mobile technology, these companies are working to enhance patient engagement, improve health outcomes, and reduce costs for both providers and patients. The competitive dynamics are shaped by factors such as regulatory compliance, reimbursement policies, and partnerships with healthcare providers, making it essential for players in this market to stay agile and responsive to changes.

Livongo has established a strong position in the US Medically Prescribed Apps Market, focusing predominantly on providing digital health solutions for chronic conditions. The company's strength lies in its ability to offer personalized insights and coaching, leveraging data collected from various sources. Livongo’s approach integrates behavioral health support with chronic condition management, creating a holistic platform that engages users actively in their healthcare journeys. The company has effectively tapped into partnerships with major employers and health plans, enhancing its market presence and accessibility to a broader audience. Livongo’s emphasis on user-centric design and proactive care management underscores its competitive advantage, catering specifically to the needs of patients managing chronic illnesses while also improving the overall efficiency of healthcare delivery.

Epic Systems plays a significant role in the US Medically Prescribed Apps Market, delivering comprehensive electronic health records and associated applications that facilitate interoperability among healthcare systems. Known for its robust suite of software solutions tailored for hospitals and healthcare organizations, Epic Systems has developed key products that include patient engagement tools, telehealth platforms, and data analytics capabilities. The company’s market presence is bolstered by a myriad of partnerships and collaborations with healthcare institutions, allowing it to maintain a competitive edge. Epic's strengths include its large user base, comprehensive service offerings, and continuous innovation to meet the demands of an evolving digital health ecosystem. The company has also engaged in strategic mergers and acquisitions, enhancing its technological capabilities and market reach, reinforcing its position as a leader in the highly competitive landscape of medically prescribed applications in the United States.

Key Companies in the US Medically Prescribed Apps Market Include

• Livongo


• Epic Systems


• Zebra Medical Vision


• Medtronic


• IBM


• Johnson and Johnson


• Fitbit


• Cerner


• Sharecare


• Omada Health


• Samsung


• Tactio Health


• Apple


• Novartis

US Medically Prescribed Apps Market Industry Developments

In the US Medically Prescribed Apps Market, significant developments have emerged, particularly with Livongo's integration into Teladoc Health, enhancing their digital health offerings, which was confirmed in October 2020. Epic Systems has continued to expand its interoperability capabilities, making strides in patient data accessibility. Zebra Medical Vision has garnered attention for their AI-driven diagnostic solutions, gaining traction among healthcare providers. Medtronic announced a partnership with IBM Watson Health in March 2022, focusing on data analytics to advance chronic disease management. Johnson and Johnson’s acquisition of Auris Health in February 2019, along with Fitbit’s ongoing enhancements in health tracking technology, exemplifies a growing investment in digital health innovations.

Cerner has also expanded its systems to support remote patient monitoring, significantly impacting care delivery. In December 2022, Omada Health partnered with Samsung to launch a digital health program aimed at chronic disease intervention. The current market valuation reflects robust growth driven by an increased demand for remote health solutions, a trend accelerated by the COVID-19 pandemic, highlighting the importance of integrating technology within traditional healthcare frameworks to improve patient outcomes.

US Medically Prescribed Apps Market Segmentation Insights

Medically Prescribed Apps Market Type Outlook

• wellness management app


• treatment management app


• disease management app


• women health pregnancy app


• disease-specific app


• others

Medically Prescribed Apps Market Device Outlook

• personal digital assistant


• tablet


• computer


• smartphone


• others

Medically Prescribed Apps Market Operating System Outlook

• android


• windows


• ios system


• others

Medically Prescribed Apps Market Application Outlook

• diabetic management


• multi-parameter tracker


• cardiac monitoring


• others

Report Scope:

Report Attribute/Metric Source:	Details
MARKET SIZE 2018	3.64(USD Billion)
MARKET SIZE 2024	4.5(USD Billion)
MARKET SIZE 2035	25.2(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	16.955% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Livongo, Epic Systems, Zebra Medical Vision, Medtronic, IBM, Johnson and Johnson, Fitbit, Cerner, Sharecare, Omada Health, Samsung, Tactio Health, Apple, Novartis
SEGMENTS COVERED	Type, Device, Operating System, Application
KEY MARKET OPPORTUNITIES	Increased chronic disease management apps, Telehealth integration expansion, Patient adherence monitoring solutions, Mental health support applications, Regulatory support for app development
KEY MARKET DYNAMICS	increased chronic disease management, regulatory approval challenges, growing patient engagement, healthcare reimbursement changes, technological integration in healthcare
COUNTRIES COVERED	US